Financials data is unavailable for this security.
View more
Year on year Jin Medical International Ltd grew revenues 3.29% from 19.19m to 19.82m while net income improved 6.34% from 2.71m to 2.88m.
Gross margin | 34.73% |
---|---|
Net profit margin | 13.99% |
Operating margin | 11.55% |
Return on assets | 7.80% |
---|---|
Return on equity | 11.67% |
Return on investment | 11.27% |
More ▼
Cash flow in USDView more
In 2023, Jin Medical International Ltd increased its cash reserves by 44.59%, or 2.14m. Cash Flow from Financing totalled 6.91m or 34.86% of revenues. In addition the company generated 3.11m in cash from operations while cash used for investing totalled 7.73m.
Cash flow per share | 0.0196 |
---|---|
Price/Cash flow per share | 82.70 |
Book value per share | 0.1676 |
---|---|
Tangible book value per share | 0.1605 |
More ▼
Balance sheet in USDView more
Current ratio | 2.58 |
---|---|
Quick ratio | 2.27 |
Total debt/total equity | 0.3689 |
---|---|
Total debt/total capital | 0.2702 |
More ▼
Growth rates in USD
Year on year, growth in earnings per share excluding extraordinary items increased 17.20%. Additionally, five year annualized earnings per share growth ranks above the industry average relative to its peers.
EPS growth(5 years) | 21.92 |
---|---|
EPS (TTM) vs TTM 1 year ago | -16.49 |